Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
无创基因分型和早期疾病动态分析表明，在TRIANGLE试验中，伊布替尼联合免疫化疗治疗套细胞淋巴瘤患者疗效显著。
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02787-0
Khouja, Mouhamad; Genuardi, Elisa; Ferrero, Simone; Laqua, Anna; Alessandria, Beatrice; Verhagen, Onno J H M; Homburg, Christa H E; Sanz, Ramón García; Medina Herrera, Alejandro; van der Velden, Vincent H J; da Silva, Maria Gomes; Gameiro, Paula; Doorduijn, Jeanette; Giné, Eva; Visco, Carlo; Brüggemann, Monika; Baldus, Claudia D; Ladetto, Marco; Schmidt, Christian; Dreyling, Martin; Jiang, Linmiao; Hoster, Eva; Darzentas, Nikos; Pal, Karol; Chitadze, Guranda; Stewart, James Peter; Gonzalez, David; Pott, Christiane
